UroPharma
PrivateLast Round
Early Funding
May 21, 2018
Total Funding Raised
$2.04M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
UroPharma operates in Healthcare & Life Sciences and is based in Norwich. Its latest recorded funding round was a Seed round in May 2018.
UroPharma is a MedTech company that develops precision drug-device platforms for direct-to-bladder therapies to treat urological and urogynecological diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
UroPharma Comparables
Compare UroPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Physion S.r.l. | 88% | |
| Combat Medical | 82% | |
| Vensica Medical | 80% |
For institutional investors. Book with your work email.
UroPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 21, 2018 | ||||
| Seed | May 21, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
UroPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 59% MoM.
- Jul 25, 2026
Monthly visitors grew 187% MoM.
For institutional investors. Book with your work email.
UroPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about UroPharma's valuation, stock price, and market status.
Is UroPharma a public or private company?
UroPharma is a private company.
What is the current stock price of UroPharma?
UroPharma is a private company, so its shares have no public market price. Caplight tracks UroPharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is UroPharma worth (valuation)?
Valuation information for UroPharma is not publicly available.
Can I buy UroPharma stock?
UroPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was UroPharma's last funding round?
UroPharma's most recent funding round was Early Funding on May 21, 2018.
Who are the main investors in UroPharma?
Key investors in UroPharma include Innovate UK.
Will UroPharma IPO soon?
No public IPO plans have been announced for UroPharma.
How can I track UroPharma secondary market activity?
Caplight tracks bids, offers, and trades in UroPharma's shares on secondary markets.